Graf Akcie NYMX (Nymox Pharmaceutical Corp). Diskuze k akciím NYMX. Aktuální informace NYMX.

Základní informace o společnosti Nymox Pharmaceutical Corp (Akcie NYMX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 167.23M
Hodnota podniku (EV) 170.02M
Tržby 0.00
EBITDA -11.51
Zisk -12.61
Růst v tržbách Q/Q N/A %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) N/A
Forward P/E N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales N/A
P/FCF N/A
Price/Book 77.29
Účetní hodnota na akcii 0.03
Hotovost na akcii 0.01
FCF vůči ceně -6.13 %
Počet zaměstnanců 3
Tržba na zaměstnance N/A
Profit margin -234,760.00 %
Operating margin N/A %
Gross margin 20.00 %
EBIT margin N/A %
EBITDA margin N/A %
EPS - Zisk na akcii N/A
EPS - Kvartální růst N/A %
EPS - Očekávaný růst příští rok N/A %
Return on assets -277.07 %
Return on equity -472.18 %
ROIC -238.41 %
ROCE -250.74 %
Dluhy/Equity 1.02
Čistý dluh/EBITDA N/A
Current ratio 3.83
Quick Ratio 3.80
Volatilita 5.67
Beta 1.18
RSI 50.83
Cílová cena analytiků 9
Známka akcie (dle analytiků) N/A
Insider ownership 44.97 %
Institutional ownership 6.93 %
Počet akcií 82.381M
Procento shortovaných akcií 5.33 %
Short ratio 7.18 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2015
Země 0

Finanční výsledky akcie NYMX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$0.116$0.299$0.224$0.284$2.761$2.95
Cost Of Goods Sold$0.058$0.138$0.149$0.173$0.16$0.174
Gross Profit$0.058$0.161$0.075$0.111$2.601$2.776
Research And Development Expenses$7.377$6.677$7.874$6.798$8.65$4.497
SG&A Expenses$6.006$4.125$5.436$6.182$11.612$3.004
Other Operating Income Or Expenses------
Operating Expenses$13.441$10.94$13.459$13.153$20.422$7.674
Operating Income$-13.325$-10.641$-13.235$-12.869$-17.66$-4.725
Total Non-Operating Income/Expense$0.163$0.047$-0.194$-0.24$-0.234$-0.111
Pre-Tax Income$-13.162$-10.594$-13.429$-13.11$-17.894$-4.646
Income Taxes------
Income After Taxes$-13.162$-10.594$-13.429$-13.11$-17.894$-4.646
Other Income------
Income From Continuous Operations$-13.162$-10.594$-13.429$-13.11$-17.894$-4.646
Income From Discontinued Operations------
Net Income$-13.162$-10.594$-13.429$-13.11$-17.894$-4.594
EBITDA$-12.76$-10.638$-13.234$-12.866$-17.654$-4.718
EBIT$-13.325$-10.641$-13.235$-12.869$-17.66$-4.725
Basic Shares Outstanding696053463735
Shares Outstanding696053463735
Basic EPS$-0.19$-0.18$-0.26$-0.28$-0.48$-0.13
EPS - Earnings Per Share$-0.19$-0.18$-0.26$-0.28$-0.48$-0.13
# 2020 2019 2018 2017 2016 2015
Current Ratio2.61437.4730.43091.48980.30720.3112
Long-term Debt / Capital---1.3493-0.4203-0.2076
Debt/Equity Ratio----3.8631-0.2959-0.1719
Gross Margin5053.846233.482139.084594.194294.112
Operating Margin-11487.07-3558.863-5908.482-4531.338-639.5729-160.1862
EBIT Margin-11487.07-3558.863-5908.482-4531.338-639.5729-160.1862
EBITDA Margin-11000-3557.86-5908.035-4530.281-639.3556-159.9608
Pre-Tax Profit Margin-11346.55-3543.144-5995.089-4616.197-648.0314-157.5209
Net Profit Margin-11346.55-3543.144-5995.089-4616.197-648.0314-155.7579
Asset Turnover0.02110.0370.22880.13813.87692.0734
Inventory Turnover Ratio2.52173.36599.933357.66674.25871.9675
Receiveable Turnover6.444421.35712.574731.55569.90974.3682
Days Sales In Receivables56.637917.0903141.763411.566936.832883.5592
ROE - Return On Equity-381.7288-151.29971073.4685417.257649.9737111.1254
Return On Tangible Equity-381.7285-151.29961073.4615417.353649.9747111.1255
ROA - Return On Assets-239.7887-131.1788-1371.706-637.3359-2512.368-326.5995
ROI - Return On Investment-381.7285-151.29961073.461-1900923.1554134.1982
Book Value Per Share0.04840.1083-0.0222-0.0049-0.064-0.1166
Operating Cash Flow Per Share0.0211-0.0111-0.02040.00280.05610.0403
Free Cash Flow Per Share0.0217-0.0117-0.02030.00270.05620.0404